Altimmune, Inc. Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Altimmune, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • Altimmune, Inc. Return On Assets for the quarter ending September 30, 2024 was -57.5 %, a 36.3% decline year-over-year.
  • Altimmune, Inc. annual Return On Assets for 2023 was -47.3 %, a 18.4% decline from 2022.
  • Altimmune, Inc. annual Return On Assets for 2022 was -40 %, a 0.58% decline from 2021.
  • Altimmune, Inc. annual Return On Assets for 2021 was -39.7 %, a 28.6% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -57.5 -15.3 -36.3% Jul 1, 2024 Sep 30, 2024
Q2 2024 -54.9 -14.3 -35.4% Apr 1, 2024 Jun 30, 2024
Q1 2024 -49.6 -8.37 -20.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -47.3 -7.35 -18.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 -42.2 -1.74 -4.3% Jul 1, 2023 Sep 30, 2023
Q2 2023 -40.5 +3.98 +8.94% Apr 1, 2023 Jun 30, 2023
Q1 2023 -41.2 +3.09 +6.98% Jan 1, 2023 Mar 31, 2023
Q4 2022 -40 -0.23 -0.58% Oct 1, 2022 Dec 31, 2022
Q3 2022 -40.5 -7.04 -21.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -44.5 -17.3 -63.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -44.3 -15.8 -55.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 -39.7 -8.84 -28.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -33.4 +4.91 +12.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 -27.2 +26.2 +49% Apr 1, 2021 Jun 30, 2021
Q1 2021 -28.4 +11 +27.8% Jan 1, 2021 Mar 31, 2021
Q4 2020 -30.9 +3.62 +10.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -38.3 +30.3 +44.2% Jul 1, 2020 Sep 30, 2020
Q2 2020 -53.4 +1.64 +2.98% Apr 1, 2020 Jun 30, 2020
Q1 2020 -39.4 +28.3 +41.8% Jan 1, 2020 Mar 31, 2020
Q4 2019 -34.5 +36.5 +51.4% Oct 1, 2019 Dec 31, 2019
Q3 2019 -68.7 -27.6 -67.2% Jul 1, 2019 Sep 30, 2019
Q2 2019 -55.1 +26.5 +32.5% Apr 1, 2019 Jun 30, 2019
Q1 2019 -67.7 -5.4 -8.67% Jan 1, 2019 Mar 31, 2019
Q4 2018 -71 +3.56 +4.77% Oct 1, 2018 Dec 31, 2018
Q3 2018 -41.1 -113 -157% Jul 1, 2018 Sep 30, 2018
Q2 2018 -81.6 -172 -191% Apr 1, 2018 Jun 30, 2018
Q1 2018 -62.3 -180 -153% Jan 1, 2018 Mar 31, 2018
Q4 2017 -74.6 -199 -160% Oct 1, 2017 Dec 31, 2017
Q3 2017 71.7 +88.9 Jul 1, 2017 Sep 30, 2017
Q2 2017 89.9 +115 Apr 1, 2017 Jun 30, 2017
Q1 2017 117 +147 Jan 1, 2017 Mar 31, 2017
Q4 2016 124 +140 Oct 1, 2016 Dec 31, 2016
Q3 2016 -17.2 +4.1 +19.3% Jul 1, 2016 Sep 30, 2016
Q2 2016 -24.7 +10.1 +29% Apr 1, 2016 Jun 30, 2016
Q1 2016 -29.9 -0.88 -3.04% Jan 1, 2016 Mar 31, 2016
Q4 2015 -15.5 +37.7 +70.9% Oct 1, 2015 Dec 31, 2015
Q3 2015 -21.3 +45.8 +68.3% Jul 1, 2015 Sep 30, 2015
Q2 2015 -34.8 +30.9 +47% Apr 1, 2015 Jun 30, 2015
Q1 2015 -29 +32.9 +53.1% Jan 1, 2015 Mar 31, 2015
Q4 2014 -53.2 +2.44 +4.39% Oct 1, 2014 Dec 31, 2014
Q3 2014 -67.1 -29 -76.1% Jul 1, 2014 Sep 30, 2014
Q2 2014 -65.7 -44.9 -215% Apr 1, 2014 Jun 30, 2014
Q1 2014 -61.9 -42.9 -227% Jan 1, 2014 Mar 31, 2014
Q4 2013 -55.6 -34.8 -168% Oct 1, 2013 Dec 31, 2013
Q3 2013 -38.1 -25.9 -211% Jul 1, 2013 Sep 30, 2013
Q2 2013 -20.9 -9.14 -78.1% Apr 1, 2013 Jun 30, 2013
Q1 2013 -18.9 -0.5 -2.71% Jan 1, 2013 Mar 31, 2013
Q4 2012 -20.8 Oct 1, 2012 Dec 31, 2012
Q3 2012 -12.2 Jul 1, 2012 Sep 30, 2012
Q2 2012 -11.7 Mar 31, 2012 Jun 30, 2012
Q1 2012 -18.4 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.